VOR

Vor Biopharma (VOR)

About Vor Biopharma (VOR)

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Details

Daily high

$15.45

Daily low

$14.40

Price at open

$14.42

52 Week High

$65.80

52 Week Low

$2.62

Market cap

627.8M

Dividend yield

0.00%

Volume

547,070

Avg. volume

658,618

P/E ratio

-.04

Vor Biopharma News